Nightingale Health

The company has received 3 proteomics orders in a short space of time.

The new contracts put upward pressure on our forecasts for the current financial year.

The protein analysis project will generate significant growth for the current fiscal year.

North Karelia is adopting risk tests as part of statutory health checks.

To the best of our knowledge, this is the company’s most valuable commercial contract to date and demonstrates once again the company’s ability to carry out large-scale research projects.

The service agreement opens a new distribution channel to the Caribbean and the British Crown Dependencies.

Numerous small contracts support our growth forecasts.